Thomson Horstmann & Bryant, Inc." »

Halozyme Therapeutics shares owned by Thomson Horstmann & Bryant, Inc."

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Thomson Horstmann & Bryant, Inc." from 13F filings

Historical chart of Thomson Horstmann & Bryant, Inc." investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Thomson Horstmann & Bryant, Inc." consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Thomson Horstmann & Bryant, Inc."

Quarter filed Position value Share count Share price at filing
2020-12-31 $1.2M 28k 42.71
2020-09-30 $741k 28k 26.26
2020-06-30 $619k 23k 26.78